Mersana Therapeutics (MRSN)
(Delayed Data from NSDQ)
$2.19 USD
+0.07 (3.30%)
Updated Sep 19, 2024 04:00 PM ET
After-Market: $2.19 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/5/24 |
---|---|
Current Quarter | -0.19 |
EPS Last Quarter | -0.20 |
Last EPS Surprise | -11.11% |
ABR | 1.40 |
Earnings ESP
|
10.53% |
---|---|
Current Year | -0.72 |
Next Year | -0.70 |
EPS (TTM) | -0.87 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 8.06M | 6.61M | 23.25M | 28.52M |
# of Estimates | 4 | 4 | 5 | 4 |
High Estimate | 13.00M | 11.80M | 32.90M | 42.80M |
Low Estimate | 2.29M | 2.29M | 11.50M | 16.61M |
Year ago Sales | 7.70M | 10.70M | 36.85M | 23.25M |
Year over Year Growth Est. | 4.64% | -38.25% | -36.93% | 22.69% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.19 | -0.17 | -0.72 | -0.70 |
# of Estimates | 5 | 4 | 5 | 5 |
Most Recent Consensus | -0.19 | -0.18 | -0.72 | -0.59 |
High Estimate | -0.15 | -0.12 | -0.62 | -0.44 |
Low Estimate | -0.23 | -0.23 | -0.81 | -0.90 |
Year ago EPS | -0.35 | -0.16 | -1.48 | -0.72 |
Year over Year Growth Est. | 45.71% | -6.25% | 51.35% | 2.78% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 1 | 1 |
Down Last 60 Days | 2 | 2 | 3 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.19 | -0.17 | -0.72 | -0.70 |
7 Days Ago | -0.19 | -0.17 | -0.72 | -0.70 |
30 Days Ago | -0.20 | -0.18 | -0.63 | -0.69 |
60 Days Ago | -0.19 | -0.18 | -0.60 | -0.70 |
90 Days Ago | -0.19 | -0.18 | -0.60 | -0.70 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.17 | -0.16 | -0.69 | -0.67 |
Zacks Consensus Estimate | -0.19 | -0.17 | -0.72 | -0.70 |
Earnings ESP | 10.53% | 7.25% | 4.43% | 4.56% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.20 | -0.16 | -0.16 | -0.35 | NA |
Estimate | -0.18 | -0.18 | -0.20 | -0.31 | NA |
Difference | -0.02 | 0.02 | 0.04 | -0.04 | 0.00 |
Surprise | -11.11% | 11.11% | 20.00% | -12.90% | 1.78% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more